Increased serum myeloid-related protein 8/14 level is associated with atherosclerosis in type 2 diabetic patients

Cardiovascular Diabetology

Volumn 10, Issue , 2011, Pages

  Peng, Wen H ^a   Jian, Wei X ^b   Li, Hai L ^a   Hou, Lei ^a   Wei, Yi D ^a   Li, Wei M ^a   Xu, Ya W ^a  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Intima media thickness; MRP8 14Diabetes mellitusCoronary artery disease

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; C REACTIVE PROTEIN; CALCIUM BINDING PROTEIN; CHOLESTEROL; CREATININE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MYELOID RELATED PROTEIN 14; MYELOID RELATED PROTEIN 8; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; ADVANCED GLYCOSYLATION END PRODUCT RECEPTOR; ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; BIOLOGICAL MARKER; CALGRANULIN A; CALGRANULIN B; IMMUNOGLOBULIN RECEPTOR;

ADULT; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CAROTID ARTERY; CORONARY ARTERY DISEASE; DIABETIC PATIENT; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; HYPERTENSION; INTIMA; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN BLOOD LEVEL; SMOKING; AGED; ANGIOCARDIOGRAPHY; BLOOD; CAROTID ARTERY DISEASE; CHI SQUARE DISTRIBUTION; CHINA; DIABETIC ANGIOPATHY; ECHOGRAPHY; HOSPITALIZATION; MIDDLE AGED; PREDICTIVE VALUE; RADIOGRAPHY; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; TUNICA MEDIA; UPREGULATION;

AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CALGRANULIN A; CALGRANULIN B; CAROTID ARTERIES; CAROTID ARTERY DISEASES; CHI-SQUARE DISTRIBUTION; CHINA; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RECEPTORS, IMMUNOLOGIC; RISK ASSESSMENT; RISK FACTORS; ROC CURVE; SEVERITY OF ILLNESS INDEX; TUNICA INTIMA; TUNICA MEDIA; UP-REGULATION;

EID: 79955966412     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-10-41     Document Type: Article

References (32)

1. Johansen OE, Birkeland KI. Preventing macrovascular disease in patients with type 2 diabetes mellitus. Am J Cardiovasc Drugs 2003, 3(4):283-297. 10.2165/00129784-200303040-00007, 14728081.
2. Lind L. Circulating markers of inflammation and atherosclerosis. Atherosclerosis 2003, 169(2):203-214. 10.1016/S0021-9150(03)00012-1, 12921971.
3. Ehrchen JM, Sunderkotter C, Foell D, Vogl T, Roth J. The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer. Journal of leukocyte biology 2009, 86(3):557-566. 10.1189/jlb.1008647, 19451397.
4. Bouzidi F, Doussiere J. Binding of arachidonic acid to myeloid-related proteins (S100A8/A9) enhances phagocytic NADPH oxidase activation. Biochemical and biophysical research communications 2004, 325(3):1060-1065. 10.1016/j.bbrc.2004.10.134, 15541396.
5. Kerkhoff C, Nacken W, Benedyk M, Dagher MC, Sopalla C, Doussiere J. The arachidonic acid-binding protein S100A8/A9 promotes NADPH oxidase activation by interaction with p67phox and Rac-2. Faseb J 2005, 19(3):467-469.
6. Schenten V, Brechard S, Plancon S, Melchior C, Frippiat JP, Tschirhart EJ. iPLA(2), a novel determinant in Ca(2+)- and phosphorylation-dependent S100A8/A9 regulated NOX2 activity. Biochimica et biophysica acta 1803(7):840-847.
7. Vogl T, Tenbrock K, Ludwig S, Leukert N, Ehrhardt C, van Zoelen MA, Nacken W, Foell D, van der Poll T, Sorg C, Roth J. Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock. Nature medicine 2007, 13(9):1042-1049. 10.1038/nm1638, 17767165.
8. Ghavami S, Rashedi I, Dattilo BM, Eshraghi M, Chazin WJ, Hashemi M, Wesselborg S, Kerkhoff C, Los M. S100A8/A9 at low concentration promotes tumor cell growth via RAGE ligation and MAP kinase-dependent pathway. Journal of leukocyte biology 2008, 83(6):1484-1492. 10.1189/jlb.0607397, 2737328, 18339893.
9. Polak JF. Carotid intima-media thickness: an early marker of cardiovascular disease. Ultrasound quarterly 2009, 25(2):55-61. 10.1097/RUQ.0b013e3181a901ab, 20068509.
10. Chen YS, Yan W, Geczy CL, Brown MA, Thomas R. Serum levels of soluble receptor for advanced glycation end products and of S100 proteins are associated with inflammatory, autoantibody, and classical risk markers of joint and vascular damage in rheumatoid arthritis. Arthritis research & therapy 2009, 11(2):R39. 10.1186/ar2645, 21594750.
11. Ehlermann P, Eggers K, Bierhaus A, Most P, Weichenhan D, Greten J, Nawroth PP, Katus HA, Remppis A. Increased proinflammatory endothelial response to S100A8/A9 after preactivation through advanced glycation end products. Cardiovascular diabetology 2006, 5:6. 10.1186/1475-2840-5-6, 1475836, 16573830.
12. Basta G. Receptor for advanced glycation endproducts and atherosclerosis: From basic mechanisms to clinical implications. Atherosclerosis 2008, 196(1):9-21. 10.1016/j.atherosclerosis.2007.07.025, 17826783.
13. Lu L, Pu LJ, Zhang Q, Wang LJ, Kang S, Zhang RY, Chen QJ, Wang JG, De Caterina R, Shen WF. Increased glycated albumin and decreased esRAGE levels are related to angiographic severity and extent of coronary artery disease in patients with type 2 diabetes. Atherosclerosis 2009, 206(2):540-545. 10.1016/j.atherosclerosis.2008.12.045, 19368923.
14. Yan XX, Lu L, Peng WH, Wang LJ, Zhang Q, Zhang RY, Chen QJ, Shen WF. Increased serum HMGB1 level is associated with coronary artery disease in nondiabetic and type 2 diabetic patients. Atherosclerosis 2009, 205(2):544-548. 10.1016/j.atherosclerosis.2008.12.016, 19150066.
15. Peng WH, Lu L, Hu J, Yan XX, Zhang Q, Zhang RY, Chen QJ, Shen WF. Decreased serum esRAGE level is associated with angiographically determined coronary plaque progression in diabetic patients. Clinical biochemistry 2009, 42(12):1252-1259. 10.1016/j.clinbiochem.2009.04.017, 19439163.
16. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998, 15(7):539-553. 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S, 9686693.
17. Wang W, Peng W, Zhang X, Lu L, Zhang R, Zhang Q, Wang L, Chen Q, Shen W. Chromosome 9p21.3 polymorphism in a Chinese Han population is associated with angiographic coronary plaque progression in non-diabetic but not in type 2 diabetic patients. Cardiovasc Diabetol 2010, 9:33. 10.1186/1475-2840-9-33, 2924260, 20691078.
18. Berry C, L'Allier PL, Gregoire J, Lesperance J, Levesque S, Ibrahim R, Tardif JC. Comparison of intravascular ultrasound and quantitative coronary angiography for the assessment of coronary artery disease progression. Circulation 2007, 115(14):1851-1857. 10.1161/CIRCULATIONAHA.106.655654, 17389269.
19. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976, 16(1):31-41. 10.1159/000180580, 1244564.
20. Foell D, Roth J. Proinflammatory S100 proteins in arthritis and autoimmune disease. Arthritis and rheumatism 2004, 50(12):3762-3771. 10.1002/art.20631, 15593206.
21. Morrow DA, Wang Y, Croce K, Sakuma M, Sabatine MS, Gao H, Pradhan AD, Healy AM, Buros J, McCabe CH, Cannon CP, Braunwald E, Simon DI. Myeloid-related protein 8/14 and the risk of cardiovascular death or myocardial infarction after an acute coronary syndrome in the Pravastatin or Atorvastatin Evaluation and Infection Therapy: Thrombolysis in Myocardial Infarction (PROVE IT-TIMI 22) trial. American heart journal 2008, 155(1):49-55. 10.1016/j.ahj.2007.08.018, 2645040, 18082488.
22. Miyamoto S, Ueda M, Ikemoto M, Naruko T, Itoh A, Tamaki S, Nohara R, Terasaki F, Sasayama S, Fujita M. Increased serum levels and expression of S100A8/A9 complex in infiltrated neutrophils in atherosclerotic plaque of unstable angina. Heart (British Cardiac Society) 2008, 94(8):1002-1007.
23. Altwegg LA, Neidhart M, Hersberger M, Muller S, Eberli FR, Corti R, Roffi M, Sutsch G, Gay S, von Eckardstein A, Wischnewsky MB, Luscher TF, Maier W. Myeloid-related protein 8/14 complex is released by monocytes and granulocytes at the site of coronary occlusion: a novel, early, and sensitive marker of acute coronary syndromes. European heart journal 2007, 28(8):941-948. 10.1093/eurheartj/ehm078, 17387139.
24. Frosch M, Vogl T, Seeliger S, Wulffraat N, Kuis W, Viemann D, Foell D, Sorg C, Sunderkotter C, Roth J. Expression of myeloid-related proteins 8 and 14 in systemic-onset juvenile rheumatoid arthritis. Arthritis and rheumatism 2003, 48(9):2622-2626. 10.1002/art.11177, 13130482.
25. Jung DY, Park JB, Lee EN, Lee HA, Joh JW, Kwon CH, Ki CS, Lee SY, Kim SJ. Combined use of myeloid-related protein 8/14 and procalcitonin as diagnostic markers for acute allograft rejection in kidney transplantation recipients. Transplant immunology 2008, 18(4):338-343. 10.1016/j.trim.2007.10.004, 18158120.
26. Ionita MG, Vink A, Dijke IE, Laman JD, Peeters W, van der Kraak PH, Moll FL, de Vries JP, Pasterkamp G, de Kleijn DP. High levels of myeloid-related protein 14 in human atherosclerotic plaques correlate with the characteristics of rupture-prone lesions. Arteriosclerosis, thrombosis, and vascular biology 2009, 29(8):1220-1227. 10.1161/ATVBAHA.109.190314, 19520974.
27. Croce K, Gao H, Wang Y, Mooroka T, Sakuma M, Shi C, Sukhova GK, Packard RR, Hogg N, Libby P, Simon DI. Myeloid-related protein-8/14 is critical for the biological response to vascular injury. Circulation 2009, 120(5):427-436. 10.1161/CIRCULATIONAHA.108.814582, 3070397, 19620505.
28. Bouma G, Lam-Tse WK, Wierenga-Wolf AF, Drexhage HA, Versnel MA. Increased serum levels of MRP-8/14 in type 1 diabetes induce an increased expression of CD11b and an enhanced adhesion of circulating monocytes to fibronectin. Diabetes 2004, 53(8):1979-1986. 10.2337/diabetes.53.8.1979, 15277376.
29. Burkhardt K, Schwarz S, Pan C, Stelter F, Kotliar K, Von Eynatten M, Sollinger D, Lanzl I, Heemann U, Baumann M. Myeloid-related protein 8/14 complex describes microcirculatory alterations in patients with type 2 diabetes and nephropathy. Cardiovascular diabetology 2009, 8:10. 10.1186/1475-2840-8-10, 2654885, 19232095.
30. Lundby-Christensen L, Almdal TP, Carstensen B, Tarnow L, Wiinberg N. Carotid intima-media thickness in individuals with and without type 2 diabetes: a reproducibility study. Cardiovascular diabetology 2010, 9:40. 10.1186/1475-2840-9-40, 2931499, 20727128.
31. Yonekura H, Yamamoto Y, Sakurai S, Petrova RG, Abedin MJ, Li H, Yasui K, Takeuchi M, Makita Z, Takasawa S, Okamoto H, Watanabe T, Yamamoto H. Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury. The Biochemical journal 2003, 370(Pt 3):1097-1109. 1223244, 12495433.
32. Koyama H, Yamamoto H, Nishizawa Y. RAGE and soluble RAGE: potential therapeutic targets for cardiovascular diseases. Molecular medicine (Cambridge, Mass 2007, 13(11-12):625-635.